| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Benitec Biopharma Inc. (BNTC) has 10 insiders with recent SEC Form 4 filings, including 32 buys and 0 sells. BNTC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 1.85M | $19.98M | - | |
| COO | 500.0K | $5.41M | - | |
| CEO | 450.0K | $4.86M | - | |
| CFO | 200.0K | $2.16M | - | |
| Dir | 35.0K | $378.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Suvretta Capital Management, LLC66 | - | Buy | 144,223 | $13.20 | $1,903,132.88 | +0.4% | -25.4% | - | |
| Dec 22, 2025 | Suvretta Capital Management, LLC66 | - | Buy | 46,141 | $11.68 | $538,972.28 | +0.1% | -9.4% | - | |
| Nov 7, 2025 | Suvretta Capital Management, LLC66 | - | Buy | 1,481,481 | $13.50 | $19,999,993.50 | +15.0% | -8.9% | - | |
| Mar 31, 2025 | Suvretta Capital Management, LLC66 | - | Buy | 16,497 | $12.83 | $211,736.04 | - | -10.1% | -18.1% | |
| Mar 26, 2025 | Suvretta Capital Management, LLC66 | - | Buy | 900,000 | $13.00 | $11,700,000.00 | +10.0% | +6.9% | -22.8% | |
| Dec 24, 2024 | Suvretta Capital Management, LLC66 | - | Buy | 47,520 | $11.09 | $527,174.46 | +0.3% | +23.8% | +12.7% | |
| Dec 3, 2024 | Suvretta Capital Management, LLC66 | - | Buy | 42,000 | $9.60 | $403,200.00 | +0.5% | +24.2% | +25.8% | |
| Nov 20, 2024 | Suvretta Capital Management, LLC66 | - | Buy | 41,436 | $10.05 | $416,615.92 | +0.2% | +5.6% | +23.3% | |
| Aug 11, 2023 | Buchi J Kevin | Director | Buy | 51,813 | $0.00 | - | +18,244% | +27.8% | +217.8% | |
| Aug 11, 2023 | Boston Megan | Executive Director | Buy | 25,907 | $0.00 | - | New | +27.8% | +217.8% |